Three Spirometry‐Based At‐Risk Phenotypes Predict Incident Airflow Limitation: A Population‐Based Study
17 affiliations
- 1Department of Medicine, Pulmonary and Critical Care Medicine Clinic for Airway Infections, University Medical Centre Marburg, Philipps‐University Marburg Marburg Germany
- 2Institute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps‐University Marburg Marburg Germany
- 3Institute of Medical Informatics, University of Münster Münster Germany
- 4LungenClinic Grosshansdorf and Airway Research Center North Grosshansdorf Germany
- 5Institute of Epidemiology, Helmholtz Zentrum München ‐ German Research Center for Environmental Health (GmbH) Neuherberg Germany
- 6KORA Study Centre, University Hospital Augsburg Augsburg Germany
- 7Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich Munich Germany
- 8German Centre for Cardiovascular Research (DZHK), Partner Site: Munich Heart Alliance Munich Germany
- 9Institute and Clinic for Occupational, Social and Environmental Medicine, LMU University Hospital, LMU Munich Munich Germany
- 10Comprehensive Pneumology Center Munich (CPC‐M), Member of the German Center for Lung Research (DZL) Munich Germany
- 11Chair of Epidemiology, Institute for Medical Information Processing, Biometry and Epidemiology, Medical Faculty, Ludwig‐Maximilians‐Universität München Munich Germany
- 12Department of Internal Medicine B University Medicine Greifswald Greifswald Germany
- 13Institute for Community Medicine, University Medicine Greifswald Greifswald Germany
- 14Department of Medicine, Pulmonary and Critical Care Medicine University Medical Centre Marburg, Philipps‐University Marburg Marburg Germany
- 15German Centre for Lung Research (DZL) Marburg Germany
- 16Institute for Lung Health Giessen Germany
- 17German Centre for Infectious Disease Research (DZIF) Germany
Abstract
Background and Objective: Incident airflow limitation is frequently diagnosed at advanced stages. Identifying individuals at risk through primary care spirometry may enable earlier intervention, yet validated, pragmatic frameworks remain lacking.
Methods: We applied a framework of three mutually exclusive spirometric at‐risk phenotypes, termed Three‐Phenotype Spirometry‐Based Identification (hereafter TriSpi), to 6123 participants from two population‐based cohorts: KORA (n = 1973, 3‐year Follow‐up, derivation) and SHIP (n = 4150, 5‐year Follow‐up, validation). TriSpi+ individuals were defined as meeting criteria for one of the three phenotypes: Early airflow limitation (EAL, FEV1/FVC > 0.7 and < 10th percentile or < 0.7 and > 5th percentile), small airway dysfunction (SAD) defined using FEF50‐ or FEF75‐based thresholds; and preserved‐ratio impaired‐spirometry (PRISm). Associations with incident airflow limitation were tested using Firth's regression.
Results: EAL, PRISm, and SAD (defined using either FEF50 or FEF75‐based thresholds) were significantly associated with incident airflow limitation across cohorts and follow‐ups. TriSpi+ individuals accounted for 26%–36% of the population, identifying 74%–93% of future cases, while TriSpi+ was associated with a 10–25‐fold increase in risk. Negative predictive values exceeded 95% across definitions, and the number needed to screen among TriSpi+ individuals ranged from 7 to 13. EAL showed the strongest individual association (OR up to 53.2), while SAD was more common in younger adults.
Conclusion: Combining definitions for EAL, PRISm, and SAD enables robust prediction of incident airflow limitation. TriSpi may serve as a scalable, pragmatic approach for early risk stratification in primary care, in absence of post‐BD spirometry.
Related
- A descriptive three-domain limitation count is associated with incident cardiovascular disease across three longitudinal ageing cohorts
- Changes in Cognition, Depressive Symptoms and Functional Limitation Before and After Incident Chronic Kidney Disease: A Three-Cohort Longitudinal Study.
- Diagnostic adequacy of COPD in primary care: a population-based analysis of spirometry use and risk-factor documentation
- Pre-operative serum microRNA profiles differ between metabolic phenotypes and predict metabolic response to sleeve gastrectomy in severe obesity
- Plasma Proteomic Signatures Predict Incident Amyotrophic Lateral Sclerosis: A Prospective Study Stratified by C9orf72 Expansion.
BibTeX
@article{pott2026three,
title = {{Three Spirometry‐Based At‐Risk Phenotypes Predict Incident Airflow Limitation: A Population‐Based Study}},
author = {Hendrik Pott and Roman Martin and Wilhelm Bertrams and Mustafa Abdo and Margit Heier and Annette Peters and Beate Stubbe and Max Kutzinski and Anne Obst and Ralf Ewert and Dominik Heider and Henry Völzke and Gernot Rohde and Claus F. Vogelmeier and Bernd Schmeck and Stefan Karrasch and the KORA‐study group},
journal = {Respirology (Carlton, Vic.)},
year = {2026},
month = aug,
doi = {10.1002/resp.70296},
url = {https://doi.org/10.1002/resp.70296},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Three Spirometry‐Based At‐Risk Phenotypes Predict Incident Airflow Limitation: A Population‐Based Study
AU - Hendrik Pott
AU - Roman Martin
AU - Wilhelm Bertrams
AU - Mustafa Abdo
AU - Margit Heier
AU - Annette Peters
AU - Beate Stubbe
AU - Max Kutzinski
AU - Anne Obst
AU - Ralf Ewert
AU - Dominik Heider
AU - Henry Völzke
AU - Gernot Rohde
AU - Claus F. Vogelmeier
AU - Bernd Schmeck
AU - Stefan Karrasch
AU - the KORA‐study group
PY - 2026
DA - 2026/08/11
JO - Respirology (Carlton, Vic.)
DO - 10.1002/resp.70296
UR - https://doi.org/10.1002/resp.70296
AB - Background and Objective: Incident airflow limitation is frequently diagnosed at advanced stages. Identifying individuals at risk through primary care spirometry may enable earlier intervention, yet validated, pragmatic frameworks remain lacking. Methods: We applied a framework of three mutually exclusive spirometric at‐risk phenotypes, termed Three‐Phenotype Spirometry‐Based Identification (hereafter TriSpi), to 6123 participants from two population‐based cohorts: KORA (n = 1973, 3‐year Follow‐up, derivation) and SHIP (n = 4150, 5‐year Follow‐up, validation). TriSpi+ individuals were defined as meeting criteria for one of the three phenotypes: Early airflow limitation (EAL, FEV1/FVC > 0.7 and < 10th percentile or < 0.7 and > 5th percentile), small airway dysfunction (SAD) defined using FEF50‐ or FEF75‐based thresholds; and preserved‐ratio impaired‐spirometry (PRISm). Associations with incident airflow limitation were tested using Firth's regression. Results: EAL, PRISm, and SAD (defined using either FEF50 or FEF75‐based thresholds) were significantly associated with incident airflow limitation across cohorts and follow‐ups. TriSpi+ individuals accounted for 26%–36% of the population, identifying 74%–93% of future cases, while TriSpi+ was associated with a 10–25‐fold increase in risk. Negative predictive values exceeded 95% across definitions, and the number needed to screen among TriSpi+ individuals ranged from 7 to 13. EAL showed the strongest individual association (OR up to 53.2), while SAD was more common in younger adults. Conclusion: Combining definitions for EAL, PRISm, and SAD enables robust prediction of incident airflow limitation. TriSpi may serve as a scalable, pragmatic approach for early risk stratification in primary care, in absence of post‐BD spirometry.
SN - 1323-7799
SN - 1440-1843
ER -